Escitalopram, fluoxetine and vitagnus in premenstrual dysphoric disorder
Phase 2
Recruiting
- Conditions
- Premenstrual dysphoric disorder.Other specified mood [affective] disorders
- Registration Number
- IRCT20150630022991N13
- Lead Sponsor
- Babol University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 75
Inclusion Criteria
Confirmed diagnosis of premenstrual dysphoric disorder
To have regular menstrual periods
Assignment the informed consent form of the study
Exclusion Criteria
Polycystic ovarian disease
Irregular menstrual periods
Psychiatric disorders: dementia, psychosis, mental retardation, opium or psychoactive drugs abuse and high mood
Breast feeding
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The severity of premenstrual symptoms. Timepoint: At baseline (before initiation of the intervention) and at the end of the first, second and third months after the intervention. Method of measurement: Premenstrual Syndrome Diary (PMSD) questionnaire.
- Secondary Outcome Measures
Name Time Method The presence of psychologic symptoms. Timepoint: Before intervention and at the end of the third month after intervention. Method of measurement: Revised 90- Scale Symptom Checklist (SCL-90-R).